Mankind Pharma has completed a multi-year transformation of its global supply chain and strategic procurement function, aimed at improving access to medicines, strengthening supply reliability, and enabling disciplined growth across markets. Delivered in collaboration with Accenture, the programme embeds digital operating models powered by advanced analytics and AI across procurement, manufacturing, inventory and distribution.
At the core of the change is an integrated planning platform that links demand forecasting, production, inventory and distribution in near real time across more than 25 international markets, 30 manufacturing facilities and over 50 distribution centres. This has improved forecast accuracy, sharpened cross-functional alignment and made planning more responsive, helping reduce drug stock outs by 75 per cent and optimise inventory by up to 20 per cent.
In parallel, Mankind undertook an 18 month revamp of its sourcing and procurement set up, standardising processes, clarifying ownership and using automation to take over routine tasks. Teams can now focus more on strategic decisions and supplier partnerships, while analytics led dashboards give leadership better visibility on spending, supplier performance and risk, supporting sustainable cost efficiencies without compromising quality or compliance.
“Ensuring uninterrupted access to quality medicines today requires value chains that are intelligent, digitally enabled, and resilient by design. At Mankind, we have reimagined the traditional value chain into a life chain built to serve patients, not just processes,” said Arjun Juneja, Chief Operating Officer, Mankind Pharma Ltd. He added that integrating demand, procurement, manufacturing and execution through AI augmented insights has improved the company’s ability to anticipate demand, manage volatility and scale responsibly while staying true to its focus on availability, quality and affordability.
Jignesh Vora, managing director and lead, Life Sciences, Accenture in India, said the collaboration has helped Mankind build a more predictive and resilient supply chain and procurement ecosystem. By combining AI and data-driven capabilities with sector expertise, the transformation is designed to support better decision making at scale, improve access to medicines, and anchor long term growth in a volatile regulatory environment.
The overhaul of supply chain and procurement reinforces Mankind Pharma’s emphasis on operational excellence and resilience, while staying aligned to its purpose of delivering quality, affordable medicines. As health systems and patient needs evolve, the company is better positioned to respond with agility and consistency, strengthening trust among patients, partners and stakeholders in India and global markets.
